Pro-proliferative and inflammatory signaling converge on FoxO1 transcription factor in pulmonary hypertension
Rajkumar Savai(Goethe University Frankfurt), Soni Savai Pullamsetti(Justus-Liebig-Universität Gießen), Baktybek Kojonazarov(Cardio-Pulmonary Institute), Ralph T. Schermuly(Justus-Liebig-Universität Gießen), Christian Muecke(Max Planck Institute for Heart and Lung Research), Norbert Weißmann(Cardio-Pulmonary Institute), Mario R. Capecchi(University of Utah), Friedrich Grimminger(Justus-Liebig-Universität Gießen), Rebecca Teske(Alliance Data (United States)), Werner Seeger(Justus-Liebig-Universität Gießen), Hamza M. Al-tamari(Max Planck Institute for Heart and Lung Research), Daniel Sedding(Martin Luther University Halle-Wittenberg)
Cited by 280
Related Papers
Clinical classification of pulmonary hypertension
|Journal of the American College of Cardiology|2004|1.9k
Inhaled Iloprost for Severe Pulmonary Hypertension
|New England Journal of Medicine|2002|1.8k
Riociguat for the Treatment of Chronic Thromboembolic Pulmonary Hypertension
|New England Journal of Medicine|2013|1.4k
Reversal of experimental pulmonary hypertension by PDGF inhibition
|Journal of Clinical Investigation|2005|1.1k
The intestinal stem cell markers Bmi1 and Lgr5 identify two functionally distinct populations
|Proceedings of the National Academy of Sciences|2011|824